Calendar Genmab A/S Nasdaq

Stocks

GMAB

US3723032062

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 12/06/2026 BST			5-day change	1st Jan Change
25.08 ^USD	-0.63%		-0.28%	-18.57%

06-11	Genmab Says Subgroup Data for Follicular Lymphoma Treatment Shows 'Sustained' Efficacy Benefits	MT
06-11	Genmab A/S Presents EPCORE FL-1 Subgroup Data Demonstrating Consistent Efficacy And Safety Results For Epcoritamab In Combination With Rituximab And Lenalidomide R2 Across Relapsed Or Refractory Follicular Lymphoma Patients	CI

Chart calendar Genmab A/S

bdf85826f9ef2cb1c.UH7M1uzS0_D7aZB0RmKQQLpstrcbPbsEo7PUFg_50-k.fTq1gNv_mKe-LNQjCxXdAtkA3P0vEPJNl8mxWj_OupAZMP6PhOOdxb0k9w~0411ad8569b3079f1866a90e7079b31c

Upcoming events on Genmab A/S

06/08/2026	Earnings release - Q2 2026	16:00
05/11/2026	Earnings release - Q3 2026	16:00

Past events on Genmab A/S

07/05/2026	Earnings release - Q1 2026	16:00
07/05/2026	Earnings presentation	17:00
19/03/2026	Présentation aux Actionnaires / Analystes	13:00
19/03/2026	Annual General Meeting	13:00
17/02/2026	Earnings presentation	17:00
17/02/2026	Earnings release - Annual 2025	16:00
11/12/2025	Information meeting	16:00
06/11/2025	Earnings release - Q3 2025
06/11/2025	Earnings presentation	17:00
07/08/2025	Earnings presentation	17:00
07/08/2025	Earnings release - Q2 2025

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million DKK	Released Forecast Spread	16 474 16 380 0.58%	21 526 21 279 1.16%	23 497 23 722 -0.95%	27 645	32 414	39 181
EBITDA Million DKK	Released Forecast Spread	5 616 5 721 -1.83%	7 116 6 933 2.64%	7 175 9 059 -20.79%	8 356	11 330	16 269
EBIT Million DKK	Released Forecast Spread	5 321 5 398 -1.42%	7 003 6 441 8.72%	6 727 8 479 -20.66%	7 498	9 584	13 775
Earnings before Tax (EBT) Million DKK	Released Forecast Spread	5 637 6 236 -9.6%	9 164 7 451 22.98%	7 605 9 329 -18.48%	5 952	8 682	13 219
Net income Million DKK	Released Forecast Spread	4 352 4 989 -12.77%	7 844 5 544 41.48%	6 083 7 428 -18.11%	4 712	7 019	10 551
EPS DKK	Released Forecast Spread	66,0 76,1 -13.23%	121 85,7 41.66%	97,1 118 -17.67%	75,5	109	164
Announcement Date		14/02/24	12/02/25	17/02/26	-

Quarterly results

Fiscal Period	March	2024 S1	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 S1	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million DKK	Released Forecast Spread	9 545 9 039 5.6%	5 540 5 646 -1.89%	6 441 6 391 0.79%	4 731 5 019 -5.73%	5 934 5 812 2.11%	6 613 6 373 3.77%	6 683 6 693 -0.15%	5 691 5 673 0.33%	6 963		7 321	7 583	6 605	8 202	8 753	9 168
EBITDA Million DKK	Released Forecast Spread	2 627 2 412 8.91%	2 129 1 847 15.25%	2 275 1 966 15.72%	1 350 986 36.95%	2 412 2 207 9.32%	3 087 2 871 7.51%	499 2 370 -78.95%		3 479	3 904	3 373	3 193
EBIT Million DKK	Released Forecast Spread	2 441 2 229 9.51%	2 102 1 782 17.95%	2 191 1 945 12.67%	1 244 1 069 16.32%	2 310 2 074 11.36%	2 970 2 445 21.46%	366 2 259 -83.79%	1 143 833 37.27%	2 144		2 261	2 147	1 461	3 204	3 804	3 966
Earnings before Tax (EBT) Million DKK	Released Forecast Spread	3 843 3 374 13.9%	1 719 1 761 -2.38%	3 602 2 037 76.79%	1 615 1 214 32.96%	2 714 2 174 24.81%	3 119 2 491 25.22%	347 2 220 -84.35%	470 449 4.7%	1 670	2 285	1 745	1 715	971	2 723	3 338	3 517
Net income Million DKK	Released Forecast Spread	2 733 2 598 5.2%	1 266 1 373 -7.77%	3 845 1 606 139.45%	1 290 1 068 20.84%	2 156 1 657 30.06%	2 595 1 927 34.67%	196 1 638 -88.04%	337 374 -9.97%	1 261	1 631	1 352	1 415	757	2 124	2 603	2 743
EPS DKK	Released Forecast Spread	41,9 39,5 5.92%	19,8 21,3 -6.93%	59,6 25,0 138.85%	20,2 16,0 26.14%	34,8 24,5 42.1%	41,8 30,3 37.77%	2,97 28,5 -89.59%	5,27 5,68 -7.11%	21,0	26,4	21,7	23,0	12,1	29,9	35,6	38,0
Announcement Date		08/08/24	06/11/24	12/02/25	08/05/25	07/08/25	06/11/25	17/02/26	07/05/26	-	-	-	-	-	-	-	-

Upcoming sector events for Genmab A/S

15/06/2026	VAXCYTE, INC.	Annual General Meeting	16:30
15/06/2026	VAXCYTE, INC.	Présentation aux Actionnaires / Analystes	16:30
15/06/2026	SANBIO COMPANY LIMITED	Earnings release - Q1 2027	P
16/06/2026	NUVALENT, INC.	Présentation aux Actionnaires / Analystes	19:00
16/06/2026	NUVALENT, INC.	Annual General Meeting	19:00
16/06/2026	REMEGEN CO., LTD.	Annual General Meeting	07:00
16/06/2026	INNOCARE PHARMA LIMITED	Annual General Meeting	03:00
16/06/2026	SELLAS LIFE SCIENCES GROUP, INC.	Présentation aux Actionnaires / Analystes	13:30
16/06/2026	SELLAS LIFE SCIENCES GROUP, INC.	Annual General Meeting	13:30
16/06/2026	ARDELYX, INC.	Présentation aux Actionnaires / Analystes	13:30

Past sector events for Genmab A/S

Today	AGIOS PHARMACEUTICALS, INC.	Information meeting	14:00
12/06/2026	KURA ONCOLOGY, INC.	Information meeting	13:00
11/06/2026	ENLIVEN THERAPEUTICS, INC.	Information meeting	13:30
11/06/2026	BIOCRYST PHARMACEUTICALS, INC.	Annual General Meeting	15:00
11/06/2026	MEIRAGTX HOLDINGS PLC	Présentation aux Actionnaires / Analystes	15:00
11/06/2026	MEIRAGTX HOLDINGS PLC	Annual General Meeting	15:00
11/06/2026	JANUX THERAPEUTICS, INC.	Présentation aux Actionnaires / Analystes	21:30
11/06/2026	JANUX THERAPEUTICS, INC.	Annual General Meeting	21:30
11/06/2026	ANNEXON, INC.	Annual General Meeting	16:00
11/06/2026	ANNEXON, INC.	Présentation aux Actionnaires / Analystes	16:00

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!